1. Edoxaban in atrial fibrillation with PCI by ACS or stable CAD presentation: a pre-specified analysis of the ENTRUST-AF PCI trial. (25th November 2020) Authors: Vranckx, P; Valgimigli, M; Eckardt, L; Lewalter, T; Laeis, P; Reimitz, P.E; Smolnik, R; Zierhut, W; Tijssen, J; Goette, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of early aspirin withdrawal and continuation of ticagrelor monotherapy post PCI for STEMI. A post hoc analysis of the randomized global leaders trial. (14th October 2021) Authors: Gamal Setih, A; Hara, H; Tomaniak, M; Lunardi, M; Gao, C; Ono, M; Kawashima, H; Juni, P; Vranckx, P; Windecker, S; Hamm, C; Gabriel Steg, P; Onuma, Y; Serruys, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial. (25th November 2020) Authors: Gragnano, F; Zwahlen, M; Vranckx, P; Juni, P; Heg, D; Hamm, C; Steg, P.G; Hagenbuch, N; Gargiulo, G; Van Geuns, R.J; Huber, K; Van Amsterdam, R; Serruys, P.W; Valgimigli, M; Windecker, S Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗